Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04747236
Title A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Virginia
Indications

peripheral T-cell lymphoma

cutaneous T cell lymphoma

breast implant-associated anaplastic large cell lymphoma

nasal type extranodal NK/T-cell lymphoma

adult T-cell leukemia

angioimmunoblastic T-cell lymphoma

anaplastic large cell lymphoma

mycosis fungoides

Therapies

Pralatrexate

Belinostat

Azacitidine + Romidepsin

Gemcitabine

Romidepsin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.